Status:
TERMINATED
Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)
Lead Sponsor:
Nantes University Hospital
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of the study is to assess the sensitivity of the salivary cortisol dosage at 23 hours compared to the serum cortisol dosage at 8 am after overnight 1-mg dexamethasone suppression te...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years)
- Signed informed consent
- Subjects affiliated with an appropriate social security system
- Body mass index above 30 kg/m2 and
- Pathological waist circumference according to criteria of NCEP ATPIII (men : 94 cm and women : 80 cm)
Exclusion
- Pregnancy
- Sepsis
- Recent surgery (less than 30 days)
- Any recent severe acute conditions requiring hospitalisation (less than 30 days)
- Recent use (\< 7 days) of oral steroids, inhaled, dermal, collyrium, infiltration
- Long-term oral corticosteroids
- Nicotinic substitute or per os licorice in 2 weeks before the inclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
514 Patients enrolled
Trial Details
Trial ID
NCT01156519
Start Date
June 1 2010
End Date
March 1 2014
Last Update
July 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France